Chapter 18: Drug Therapy With Beta-Lactam Antibacterial Agents

Introduction to Beta-Lactam Antibacterials

Beta-lactam antibacterial agents are a major class of antibiotics characterized by the presence of a beta-lactam ring in their chemical structure. This ring is essential for their antibacterial activity, and its integrity is crucial for the drug's effectiveness. Disruption of the beta-lactam ring by specific bacterial enzymes leads to inactivation of the antibiotic and is a primary mechanism of bacterial resistance.

• Beta-lactam ring: A four-membered lactam (cyclic amide) structure that is central to the drug's function.

• Resistance: Bacteria may produce enzymes (beta-lactamases) that break the ring, rendering the antibiotic ineffective.

• Variety: Beta-lactam antibiotics differ widely in their chemical properties and clinical uses.

Types of Beta-Lactam Antibacterials

The beta-lactam class includes several important groups of antibiotics, each with unique characteristics and clinical applications.

• Penicillins

• Cephalosporins

• Carbapenems

• Monobactams

Mechanism of Action

Beta-lactam antibiotics exert their effect by inhibiting the synthesis of the bacterial cell wall. They bind to specific proteins (penicillin-binding proteins) involved in cell wall construction, leading to the formation of a defective cell wall and ultimately the destruction of the microorganism.

• Target: Bacterial cell wall synthesis

• Effect: Weakens the cell wall, causing cell lysis and death

Key Equation:

Penicillins

Overview and History

Penicillins were the first antibiotics developed and remain widely used due to their safety and effectiveness. Early forms had to be administered by injection because they were destroyed by stomach acid, and their use led to the emergence of resistant bacterial strains.

• Administration: Originally parenteral (injection); oral forms now available

• Resistance: Overuse has led to resistant strains, especially Staphylococcus

Pharmacokinetics

• Distribution: Widely distributed in body fluids; limited penetration into the eye and cerebrospinal fluid unless inflammation is present

• Excretion: Rapidly eliminated by the kidneys

Clinical Indications

• Effective against: Primarily gram-positive bacteria, but some activity against gram-negative organisms

• Common uses: Skin and soft tissue infections, respiratory tract infections, gastrointestinal and genitourinary infections

• Resistance: Increasing incidence of resistance among bacteria

Contraindications and Allergies

• Hypersensitivity: Allergic reactions to any penicillin preparation

• Cross-allergenicity: Possible with cephalosporins and carbapenems; avoid these in patients with life-threatening penicillin allergies

Extended-Spectrum Penicillins

These are broad-spectrum antibiotics with enhanced activity against gram-negative organisms. They are available in oral and injectable forms and are commonly used for urinary tract infections and prostatitis.

• Administration: Oral, intermittent IV, or IM

Penicillin/Beta-Lactamase Inhibitor Combinations

Beta-lactamase inhibitors have minimal antibacterial activity on their own but protect penicillins from enzymatic destruction, extending their spectrum of activity. These combinations are useful against bacteria that produce beta-lactamase enzymes.

• Mechanism: Inhibit beta-lactamase enzymes, allowing penicillins to remain effective

• Clinical use: Infections resistant to penicillin alone

Cephalosporins

Overview

Cephalosporins are a widely used group of antibiotics derived from fungi. They have a broad spectrum of activity, especially against gram-negative bacteria, and are classified into five generations based on their pharmacology and spectrum.

• Distribution: Widely distributed in body fluids and tissues; highest concentrations in liver and kidneys

• Generations: Five subgroups, each with varying activity against different bacteria

Clinical Indications

• Surgical prophylaxis

• Treatment of infections: Respiratory tract, urinary tract, skin and soft tissues, bones, joints, brain, spinal cord, and septicemia

Contraindications

• Allergy: Previous anaphylactic reaction to penicillin or cephalosporin

• Cross-sensitivity: Low risk in those with delayed reactions to penicillin (e.g., skin rash)

Carbapenems

Overview

Carbapenems are broad-spectrum, bactericidal beta-lactam antibiotics that inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins. There are four main carbapenem medications in clinical use.

• Spectrum: Broad, effective against many resistant bacteria

• Mechanism: Similar to other beta-lactams, disrupts cell wall synthesis

Monobactams

Overview and Clinical Use

Monobactams are active primarily against gram-negative bacteria, including many strains resistant to other antibiotics. They do not cause kidney or hearing damage, which can be side effects of aminoglycosides.

• Indications: Urinary tract, skin/skin structures, lower respiratory tract, intra-abdominal, gynecologic infections, and septicemia

Principles of Antimicrobial Therapy

Goals and Drug Selection

The primary goal of antimicrobial therapy is to prevent or treat infections caused by pathogenic organisms. Drug selection depends on the causative organism, severity of infection, and patient-specific factors.

• Factors influencing selection: Type of organism, infection severity, patient age, organ function, and comorbidities

Use in Special Populations

Considerations

Special populations require careful consideration when prescribing beta-lactam antibiotics. These include perioperative patients, children, older adults, and those with kidney or liver impairment, critical illness, or those receiving home care.

• Renal and hepatic impairment: Dosage adjustments may be necessary

• Children and older adults: May have different pharmacokinetics and risk of side effects

Summary Table: Major Beta-Lactam Antibiotic Classes